Connect with us

Technology

Converge Bio raises $5.5M Seed to speed up drug discovery and development with Generative AI

Published

1 year ago

on

TEL AVIV, Israel, Nov. 20, 2024 /PRNewswire/ — Converge Bio, a generative AI platform for accelerated drug discovery and development, today announced it has raised $5.5 million in seed funding, led by TLV Partners. Converge Bio’s platform uses large language models (LLMs) trained on biological and chemical data (DNA, RNA, protein sequences, and small molecules) to help biotech and pharmaceutical companies discover and develop better-performing drugs in less time.

Developing new medications and biological products is a complex, lengthy, and costly endeavor. On average, bringing a new drug to market takes about 10 years and requires an investment of approximately $1 billion. The process is fraught with risk — 90% of candidates fail during clinical trials after significant investments have been made.

Generative AI has emerged as a powerful tool for drug discovery and development, with dozens of AI-discovered drugs currently in clinical trials. “Biological languages, like DNA and RNA, aren’t just random sequences — they have intricate structures and rules, similar to the grammar and syntax of spoken languages,” said Dov Gertz, co-founder and CEO of Converge Bio. “Just like how ChatGPT can instantly generate a string of words to answer a question, a model trained on biological data can help rapidly design optimized mRNA sequences for vaccines, cutting months or years from the process.”

Converge Bio is a generative AI hub for Biotech and Pharma, enabling the accelerated discovery and development of drugs using LLMs. The platform provides a library of foundational models across all biological languages, that can be easily enhanced and fine-tuned for specific tasks with Converge Bio’s data enrichment pipeline. Converge Bio offers a variety of generative AI-based solutions, such as engineering antibodies for improved specificity and reduced side effects, identifying novel drug targets, or designing mRNA vaccines optimized to elicit strong immune responses. Converge Bio has partnered with some of the world’s largest pharmaceutical companies, including Teva, and cutting-edge drug discovery companies like Compugen and BiomX.

“Generative AI will transform every stage of drug discovery and development and our platform is at the forefront, allowing any pharma or biotech company to easily incorporate AI within their R&D pipelines,” said Gertz. “We start by predicting biological outcomes, such as how well a potential drug might work. Then, we provide explanations for these predictions in biological terms that scientists can understand and trust. Finally, we use this knowledge to generate novel biological products, like optimized drug candidates. The models are pre-trained on vast amounts of data, so they can create significant insights even from minimal fine-tuning data.”

“At TLV Partners, we invest in bold visions, and Converge Bio’s approach to integrating generative AI into the very fabric of biology blew us away,” said Shahar Tzafrir, Managing Partner at TLV Partners. “The concept of treating biological data as a language is transformative. What truly sets Converge Bio apart is their unique ability not just to predict biological outcomes but to explain the reasoning behind those predictions in a way that scientists can trust and act upon. This platform is not just advancing drug discovery but reshaping how we understand, explain, and manipulate biology itself.”

About Converge Bio

Converge Bio was founded in 2024 by a team that brings together deep scientific and technical expertise. CEO Dov Gertz holds a master’s in bioinformatics from Tel Aviv University, where he developed a machine learning pipeline to find new types of CRISPR systems used for gene editing. His research resulted in a scientific publication with Nobel laureate professor Jennifer Doudna. CTO Oded Kalev is an ML expert who previously managed an R&D Group of 20 engineers and ML experts at the cyber security company Perception Point. As an early adopter of LLMs, Oded applied these technologies during the COVID lockdowns to analyze RNA sequences of the virus, achieving state-of-the-art results in COVID variant clustering using his own GPU at home. Chief Scientific Officer Iddo Weiner, formerly VP of research at BiomX, completed his Ph.D. in engineering and biology in just two and a half years with ten peer-reviewed papers.

Media Contact :
Lazer Cohen
lazer@cocnrete.media
347-753-8256

View original content:https://www.prnewswire.com/news-releases/converge-bio-raises-5-5m-seed-to-speed-up-drug-discovery-and-development-with-generative-ai-302311612.html

SOURCE Converge Bio

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

ADT Inc. Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information

Published

24 minutes ago

on

April 28, 2026

By

National class action firm offering free case evaluations to individuals impacted by the ADT Inc. cybersecurity incident

BOCA RATON, Fla., April 27, 2026 /PRNewswire/ — Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from the ADT Inc. data breach. ADT Inc. learned of the cybersecurity incident on April 20, 2026.

What Happened

On or about April 20, 2026, ADT learned of a data breach incident that compromised customers’ personal information. The hacker group ShinyHunters has claimed responsibility for the attack.

Information Exposed

Affected personal data includes names, phone numbers, addresses, dates of birth, and the last four digits of some customers’ Social Security numbers.

Who May Be Impacted

Individuals who received a data breach notification from ADT Inc. may face an increased risk of identity theft and fraud.

Your Legal Options

Edelson Lechtzin LLP is investigating a potential class action to pursue legal remedies on behalf of individuals whose sensitive personal data may have been compromised in the ADT Inc. breach. The firm will evaluate your rights and potential claims at no cost.

Recommended Protective Steps

Review account statements and credit reports regularly and remain vigilant for suspicious activity. Confirm whether your information was involved in the ADT Inc. incident and preserve any letters or emails you received about the breach. Consider placing fraud alerts and credit monitoring.

Contact Us for a Free Case Evaluation

Speak confidentially with a data privacy attorney today: Marc Edelson, Esq., Edelson Lechtzin LLP, 411 S. State Street, Suite N-300, Newtown, PA 18940; Phone: 844-696-7492 ext. 2; Email: medelson@edelson-law.com; Web: www.edelson-law.com. Or click HERE to request a free consultation.

About ADT Inc.

Based in Boca Raton, Florida, ADT Inc. is the nation’s largest home security company, providing monitored and self-install systems, smart home features, and fire safety services.

About Edelson Lechtzin LLP

Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to data breach litigation, the firm handles class and collective actions involving securities and investment fraud, federal antitrust violations, ERISA employee benefit plans, wage theft, and consumer fraud

Media and Partnership Inquiries: Use the contact information above to connect with our team regarding interviews, co-counsel opportunities, and referral partnerships.

Legal Notice: This press release may be considered Attorney Advertising in some jurisdictions.

View original content to download multimedia:https://www.prnewswire.com/news-releases/adt-inc-data-breach-edelson-lechtzin-llp-launches-investigation-into-exposure-of-personal-information-302755096.html

SOURCE Edelson Lechtzin LLP

Continue Reading

Technology

Make It Easy to Connect Your Switch to a Larger Screen — HAILESI S123E Enters the Japanese Portable Monitor Market, Ranking Among Amazon Japan’s Top 5 Bestsellers

Published

24 minutes ago

on

April 28, 2026

By

SHENZHEN, China, April 28, 2026 /PRNewswire/ — Known for its high quality standards, Japan’s consumer electronics market has recently seen a portable monitor from Shenzhen gain increasing attention. The HAILESI S123E portable monitor has ranked among the top 5 best-selling portable monitors on Amazon Japan and holds the No.1 position in the 12.3-inch category. This achievement reflects not only strong sales growth, but also positive recognition of its quality and performance among Japanese users. (Data source: Amazon monitor category ranking, March 2026)

 

Developed under the concept of “no Switch 2 dock required”, the S123E offers a more convenient and flexible connection experience. With just a single Type-C cable, users can directly connect their gaming console to a larger screen, without relying on a traditional dock. One Japanese user commented: “This is one of the most user-friendly external monitors I’ve used. It’s lightweight and easy to carry, so I can use it anytime and anywhere. It also feels more cost-effective than buying an official dock.”

In terms of display performance, it features a 12.3-inch screen with a 1920×1280 resolution and a 3:2 aspect ratio. Compared to conventional 16:9 displays, it provides a larger viewing area, helping improve productivity for work and study. With 100% sRGB color gamut, 300 nits of brightness, and HDR support, it delivers natural and immersive visual performance across various use cases.

Touch functionality is another key highlight. The S123E adopts a fully laminated touch panel and supports AES 1.0/2.0 styluses, enabling precise input and smooth interaction, suitable for note-taking, drawing, and other creative tasks. With OTG support, users can also connect a keyboard and mouse directly, making it easy to set up a mobile workstation.

Designed to balance portability and practicality, the device features a lightweight body and an integrated adjustable stand for flexible viewing angles. Built-in dual speakers support everyday audio and video needs, making it suitable for a wide range of scenarios including gaming, work, study, and in-vehicle use.

About HAILESI

HAILESI is a technology brand specializing in display devices, with in-house R&D capabilities and a global presence. Focusing on user experience and ease of use, the company is committed to providing high-quality visual experiences and reliable services to customers worldwide.

For more details, please visit: www.hailesi.net

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/make-it-easy-to-connect-your-switch-to-a-larger-screen–hailesi-s123e-enters-the-japanese-portable-monitor-market-ranking-among-amazon-japans-top-5-bestsellers-302752759.html

SOURCE HAILESI

Continue Reading

Technology

Creator Authority Joins LinkedIn Marketing Partner Program to Help B2B Brands Launch Influencer Campaigns

Published

24 minutes ago

on

April 28, 2026

By

LOS ANGELES, April 28, 2026 /PRNewswire/ — Creator Authority, a B2B-focused influencer marketing agency, has joined the LinkedIn Marketing Partner Program, bringing its expertise, proprietary data, and full-service campaign capabilities to help brands leverage LinkedIn’s professional audience.

Creator Authority works with brands including SAP, Notion, Dropbox, HubSpot, Webflow, Upwork, Amazon, and Canva. The agency handles everything from strategy and creative direction to creator sourcing, paid amplification, compliance, and reporting.

The timing reflects a significant market shift. Investment in creator marketing has seen a 171% year-over-year increase, and 61% of B2B marketing leaders plan to increase their creator content spend. According to LinkedIn’s research, 87% of B2B buyers refer to thought leaders when making purchase decisions and 82% say creator content directly influences them.

Brendan Gahan, CEO and founder of Creator Authority, said: “We built Creator Authority because we saw what was coming. LinkedIn plays a critical role in B2B buying decisions, and creators are becoming the most trusted voices in that environment. Being part of the LinkedIn Marketing Partner Program means we can help our clients move faster, with better tools and closer collaboration with the platform.”

LinkedIn represents a unique opportunity in B2B marketing. The platform’s audience carries twice the buying power of the average web user. Thought Leader Ads deliver 252% higher CTR than conventional single-image ads. Creator-led campaigns reduce cost-per-lead by 23%. For Fortune 100 brands, creator content generates 20x the Earned Media Value of brand-owned channels.

The market is moving fast. Most B2B budgets haven’t caught up. Leading B2B brands are recognizing that success on LinkedIn isn’t about being the loudest voice, it’s about amplifying the right voices.

Jonathan Hunt, VP of HubSpot Media, said: “Creator Authority has been an incredible partner. They’ve helped HubSpot Media uncover emerging creator opportunities on LinkedIn and maximize those relationships. Their understanding of the space is unmatched, and their ability to turn that insight into a smart, scalable strategy is why we work with them.”

About Creator Authority
Creator Authority helps B2B and enterprise brands run end-to-end influencer campaigns on LinkedIn and is a member of the LinkedIn Marketing Partner Program specializing in influencer marketing. Clients include SAP, Notion, Dropbox, HubSpot, Webflow, Upwork, Amazon, and Canva.

Creator Authority was founded in 2023 by Brendan Gahan, a creator economy veteran recognized on Forbes 30 Under 30 who has been doing influencer marketing since 2006. Gahan previously built and sold Epic Signal to Mekanism, where he served as Partner and Chief Social Officer. Mekanism was later acquired by Plus Company.

View original content to download multimedia:https://www.prnewswire.com/news-releases/creator-authority-joins-linkedin-marketing-partner-program-to-help-b2b-brands-launch-influencer-campaigns-302753194.html

SOURCE Creator Authority

Continue Reading

Trending